The global Oral Proteins and Peptides Market is set to witness remarkable growth, with market valuation expected to rise from USD 6.35 billion in 2023 to USD 26.94 billion by 2031, expanding at a CAGR of 20.13% during the forecast period from 2024 to 2031.
Read Complete Report Details: https://www.kingsresearch.com/oral-proteins-and-peptides-market-1481
Market Growth Drivers and Trends
The rising prevalence of chronic diseases, particularly diabetes, gastrointestinal disorders, and hormonal imbalances, is a significant factor driving market growth. The increasing adoption of oral drug delivery methods over injectable forms due to enhanced patient compliance and convenience is further propelling the demand. Additionally, technological advancements in peptide formulation are enabling better stability, bioavailability, and absorption of oral proteins and peptides, fueling market expansion.
Segment Analysis
By Drug Type: The market is segmented into Linaclotide, Plecanatide, Calcitonin, and Others. Linaclotide and Plecanatide are leading the market, particularly in treating gastrointestinal disorders such as irritable bowel syndrome (IBS) and chronic constipation.
By Application: The market is categorized into Diabetes, Gastrointestinal Disorders, Bone Diseases, Hormonal Disorders, and Others. Diabetes management is expected to hold the largest share due to the rising incidence of diabetes worldwide and ongoing research into oral insulin formulations.
Regional Insights
North America dominates the market due to strong R&D activities, FDA approvals, and the presence of key pharmaceutical players investing in oral peptide therapeutics.
Europe is witnessing steady growth, driven by increasing healthcare expenditures and rising adoption of novel drug delivery systems.
Asia-Pacific is anticipated to exhibit the fastest growth, supported by a large patient pool, improving healthcare infrastructure, and rising demand for cost-effective treatments.
The Middle East & Africa and Latin America are gradually expanding due to increasing awareness of peptide-based therapeutics and improving healthcare access.
Future Outlook
The oral proteins and peptides industry is expected to experience a transformative shift with ongoing clinical trials, partnerships, and technological advancements in nanoformulation and drug encapsulation. Major players in the market are focusing on new product launches, regulatory approvals, and strategic collaborations to strengthen their market presence.
